[HTML][HTML] Rivaroxaban for stroke prevention after embolic stroke of undetermined source
…, A Czlonkowska, J Eckstein, RJ Gagliardi… - … England Journal of …, 2018 - Mass Medical Soc
Background Embolic strokes of undetermined source represent 20% of ischemic strokes and
are associated with a high rate of recurrence. Anticoagulant treatment with rivaroxaban, an …
are associated with a high rate of recurrence. Anticoagulant treatment with rivaroxaban, an …
Embolic strokes of undetermined source: prevalence and patient features in the ESUS Global Registry
…, N Shamalov, R Brouns, RJ Gagliardi… - … journal of stroke, 2016 - journals.sagepub.com
Background Recent evidence supports that most non-lacunar cryptogenic strokes are embolic.
Accordingly, these strokes have been designated as embolic strokes of undetermined …
Accordingly, these strokes have been designated as embolic strokes of undetermined …
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: design of the NAVIGATE ESUS randomized trial
…, D Toni, SF Ameriso, RJ Gagliardi… - European stroke …, 2016 - journals.sagepub.com
Background Embolic strokes of undetermined source comprise up to 20% of ischemic
strokes. The stroke recurrence rate is substantial with aspirin, widely used for secondary …
strokes. The stroke recurrence rate is substantial with aspirin, widely used for secondary …
Global survey of the frequency of atrial fibrillation–associated stroke: Embolic Stroke of Undetermined Source Global Registry
…, N Shamalov, R Brouns, RJ Gagliardi… - Stroke, 2016 - Am Heart Assoc
Background and Purpose— Atrial fibrillation (AF) is increasingly recognized as the single most
important cause of disabling ischemic stroke in the elderly. We undertook an international …
important cause of disabling ischemic stroke in the elderly. We undertook an international …
Stroke care trends during COVID-19 pandemic in Zanjan Province, Iran. from the cascade initiative: statistical analysis plan and preliminary results
Background The emergence of the COVID-19 pandemic has significantly impacted global
healthcare systems and this may affect stroke care and outcomes. This study examines the …
healthcare systems and this may affect stroke care and outcomes. This study examines the …
Predictors of recurrent ischemic stroke in patients with embolic strokes of undetermined source and effects of rivaroxaban versus aspirin according to risk status: the …
Background: Embolic stroke of undetermined source (ESUS) identifies patients with cryptogenic
ischemic stroke presumed due to embolism from several unidentified sources. Among …
ischemic stroke presumed due to embolism from several unidentified sources. Among …
[HTML][HTML] Interleukin-10 may protect against progressing injury during the acute phase of ischemic stroke
GG Protti, RJ Gagliardi, WCN Forte… - Arquivos de neuro …, 2013 - SciELO Brasil
Atherosclerosis is an inflammatory disease, and ischemic stroke is one of its most common
and devastating manifestations. Proinflammatory cytokines play a key role in the progression …
and devastating manifestations. Proinflammatory cytokines play a key role in the progression …
Motor cortex-induced plasticity by noninvasive brain stimulation: a comparison between transcranial direct current stimulation and transcranial magnetic stimulation
…, BO Adeyemo, LF Medeiros, F Miraval, RJ Gagliardi… - …, 2013 - journals.lww.com
The aim of this study was to test and compare the effects of a within-subject design of repetitive
transcranial magnetic stimulation (rTMS)[coupled with sham transcranial direct current …
transcranial magnetic stimulation (rTMS)[coupled with sham transcranial direct current …
Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy
…, DS Toni, N Shamalov, RJ Gagliardi… - … Journal of Stroke, 2022 - journals.sagepub.com
Background Covert brain infarcts are associated with important neurological morbidity. Their
incidence in patients with embolic stroke of undetermined source (ESUS) is unknown. Aims …
incidence in patients with embolic stroke of undetermined source (ESUS) is unknown. Aims …
Neurophysiological measurements of affected and unaffected motor cortex from a cross-sectional, multi-center individual stroke patient data analysis study
…, B Turman, S Tarlacı, RJ Gagliardi… - Neurophysiologie …, 2016 - Elsevier
Objectives Transcranial magnetic stimulation (TMS) has been used to measure cortical
excitability as a functional measurement of corticomotor pathways. Given its potential application …
excitability as a functional measurement of corticomotor pathways. Given its potential application …